Aplasia Cutis Congenita

Total Page:16

File Type:pdf, Size:1020Kb

Aplasia Cutis Congenita Aplasia Cutis Congenita Aplasia cutis congenita (ACC) is a clinical description of the i. Group IX: ACC associated with malformation syn- absence of the skin at birth, first described by Cordon in 1767. dromes It is a heterogeneous group of disorders characterized by i. Trisomy 13 absence of epidermis, dermis, and, sometimes, subcutaneous ii. Trisomy 18 tissue, muscle, or bone on one or more parts of the body. The iii. Monosomy 4 incidence is estimated to be 1 in 10,000 births. iv. Ectodermal dysplasias v. Johanson-Blizzard syndrome GENETICS/BASIC DEFECTS vi. Focal dermal hypoplasia vii. 46,XY gonadal dysgenesis 1. Etiological theories viii. Amniotic band disruption complex a. Amniogenic theory 3. Aplasia cutis congenita associated with epidermolytic i. Adhesion of the amniotic membrane to the bullosa fetal skin might tear off, leaving absent areas a. Simplex of skin i. An autosomal dominant disorder ii. Not supported by the study of placentas because ii. Lysis of the epidermis occurring within the cyto- most placentas are normal plasm of the basal cell layer b. Vascular theory: assumes thromboplastic material b. Junctional from a fetus papyraceus (mummified dead fetus) as i. An autosomal recessive disorder the causes of skin damage ii. Damage at the level of the lamina lucida c. Placental abnormalities c. Dystrophic (scarring) d. Biomechanical forces on the vertex during the i. An autosomal dominant or recessive disorder embryogenesis ii. Defect situated in the anchoring fibrils attaching e. Intrauterine trauma: a history of trauma in only a the basal lamina to the dermis minority of cases f. Intrauterine infections i. Varicella CLINICAL FEATURES ii. Herpes simplex 1. Aplasia cutis of the scalp (aplasia cutis vertices) g. Intrauterine involution of a hemangioma a. The most common form h. Teratogens b. Single or multiple noninflammatory ulcers i. Methimazole c. Occurrence at or near the scalp vertex ii. Misoprostol d. Variable in shape and size i. Genetic factors e. Heals leaving a hairless scar 2. Frieden’s classification of aplasia cutis congenita f. Occurrence a. Group I: ACC of the scalp without multiple anom- i. An isolated condition alies: sporadic occurrence or autosomal dominant ii. Associated with other congenital abnormalities inheritance 2. Aplasia cutis with extracranial symmetrical involve- b. Group II: ACC of the scalp with associated limb ment (a distinctive type of “nonscalp” aplasia cutis con- abnormalities: autosomal dominant inheritance genita) c. Group III: ACC of the scalp with associated epider- a. Linear lesions with a symmetrical pattern of distribu- mal, organoid nevus, or epidermal nevus syndrome: tion on the trunk and limbs sporadic occurrence b. Aplasia cutis with fetus papyraceous: usually associ- d. Group IV: ACC overlying embryologic malforma- ated with in utero death of a monozygotic twin dur- tions: inheritance depending on underlying conditions ing pregnancy, with or without the presence of a e. Group V: ACC with associated fetus papyraceous or fetus papyraceous (persistence of a mummified dead placental infarcts: sporadic occurrence fetus) f. Group VI: ACC associated with epidermolysis c. Other terms bullosa: autosomal dominant or recessive inheri- i. Truncal aplasia cutis tance depending on the type of the epidermolysis ii. Bilateral abdominal aplasia cutis bullosa 3. Associated congenital anomalies g. Group VII: ACC localized to extremities without blis- a. Craniofacial anomalies tering: autosomal dominant or recessive inheritance i. Microphthalmia h. Group VIII: ACC caused by specific teratogens: scalp ii. Colobomas (methimazole), any area (varicella, H. simplex) iii. Myopia 70 APLASIA CUTIS CONGENITA 71 iv. Epibulbar dermoid 5. Amniotic fluid findings in some cases v. Cleft lip a. Elevated amniotic fluid AFP levels vi. Cleft palate b. Positive acetylcholinesterase vii. Ear malformations b. CNS malformation GENETIC COUNSELING i. Hydrocephalus ii. Mental retardation 1. Recurrence risk iii. Spastic paralysis a. Patient’s sib c. Ectodermal dysplasia i. Autosomal dominant: not increased unless a par- i. Hypoplasia of the teeth ent is affected ii. Delayed dentition ii. Autosomal recessive: 25% iii. Nail hypoplasia b. Patient’s offspring iv. Skin blisters i. Autosomal dominant: 50% v. Skin hyperpigmentation ii. Autosomal recessive: not increased unless the vi. Cutis marmorata spouse is a carrier d. Gastrointestinal abnormalities 2. Prenatal diagnosis i. Tracheoesophageal fistula/esophageal atresia a. Ultrasonography for at risk family with aplasia cutis ii. Omphalocele congenita associated with epidermolysis bullosa and iii. Gastroschisis pyloric atresia iv. Pyloric atresia: especially in association with i. Hydramnios junctional (atrophicans) type of epidermolysis ii. A dilated stomach bullosa iii. A deformed external ear v. Ileal atresia iv. A contracted fisted hand vi. Mesenteric herniation b. Amniocentesis for associated chromosomal abnor- vii. Biliary atresia mality viii. Midgut atresia 3. Management ix. Intestinal lymphangiectasia a. Careful and standard wound treatment for small e. Musculoskeletal abnormalities defects involving only epidermis: usually uneventful i. Arthrogryposis healing of the lesion ii. Polydactyly b. Control of infection iii. Syndactyly c. Control of electrolyte abnormalities, especially with 4. Prognosis larger wounds a. Scalp lesion (1–3 cm): resolves spontaneously in d. Requires a scalp flap for most lesions majority of cases (>85%) e. A split-thickness skin grafting or full-thickness pedi- b. Prognosis usually determined by underlying anom- cle grafts (for defects of the scalp extending to the alies and extent of the lesions dura mater) f. Reconstruction of skull and scalp for a large lesion involving scalp, skull, and dura DIAGNOSTIC INVESTIGATIONS g. Emergency intervention to control life-threatening 1. Imaging hemorrhage a. Radiography h. Surgical intervention also useful later in life for revi- i. Scalp/skull sion of scars and correction of alopecia with rotation ii. Hands flaps, simple excision and closure, scalp reduction iii. Feet techniques, or local hair transplantation b. CT scan or MRI of the brain i. Management of associated anomalies 2. Karyotyping to detect chromosome abnormality 3. Histology: heterogeneous appearance of lesions REFERENCES a. Ulcerated lesions at birth Achiron R, Hamel-Pinchas O, Engelberg S, et al.: Aplasia cutis congenita asso- i. Complete absence of all layers of skin ciated with Epidermolysis bullosa and pyloric atresia: the diagnostic role ii. Occasionally extending to the bone or dura of prenatal ultrasonography. Prenat Diagn 12:765–771, 1992. b. In utero healing of some lesions Al-Sawan RMZ, Soni AL, Al-Kobrosly AM, et al.: Truncal aplasia cutis con- c. Healed lesions genita associated with ileal atresia and mesenteric defect. Pediatr i. Flattened epidermis Dermatol 16:408–409, 1999. Argenta LC, Dingman RO: Total reconstruction of aplasia cutis congenita ii. Proliferation of fibroblasts in a loose connective involving scalp, skull, and dura. Plast Reconstr Surg 77:650–653, 1986. tissue stroma Boente MC, Frontini MV, Acosta MI, et al.: Extensive symmetric truncal apla- iii. Newly formed capillaries sia cutis congenita without fetus papyraceous or macroscopic evidence of iv. Complete absence of adnexal structures placental abnormalities. Prenat Diagn 12:228–230, 1995. Cambiaghi S, Gelmetti C, Nicolini U: Prenatal findings in membranous apla- 4. Culture/serology sia cutis. J Am Acad Dermatol 39:638–640, 1998. a. Varicella zoster Cambiaghi S, Schiera A, Tasin L, et al.: Aplasia cutis congenita in surviving co- b. H. simplex virus twins: four unrelated cases. Pediatr Dermatol 18:511–515, 2001. 72 APLASIA CUTIS CONGENITA Carmi R, Sfer S, Karplus M, et al.: Aplasia cutis congenita in two sibs discor- Fonseca W, Alencar Am J Cardiol, Pereira RMM, et al.: Congenital malforma- dant for pyloric atresia. Am J Med Genet 11:319–329, 1982. tion of the scalp and cranium after failed first trimester abortion attempt Chitnis MR, Carachi R, Galea P. Familial aplasia cutis congenita. Eur J Pediatr with Misoprostol. Clin Dysmorphol 2:76–80, 1993. Surg 35:100–101, 1996. Frieden U: Aplasia cutis congenita: a clinical review and proposal for classifi- Classen DA: Aplasia cutis congenita associated with fetus papyraceous. Cutis cation. J Am Acad Dermatol 14:646–660, 1986. 64:104–106, 1999. Gerber M, de Veciana M, Towers CV, et al.: Aplasia cutis congenita: a rare Cowton JAL, Beattie TJ, Gibson AAM, et al.: Epidermolysis bullosa in associ- cause of elevated alpha-fetoprotein levels. Am J Obstet Gynecol ation with aplasia cutis congenita and pyloric atresia. Acta Paediatr Scand 172:1040-1041, 1995. 71:155–160, 1982. Irons GB, Olson RM: Aplasia cutis congenita. Plast Reconstr Surg 66:199–203, Cordon M: Extrait d’une lettre au sujet de trois enfants de la même mère né avec 1980. partie des extrémités denuée de peau. J Med Chir Pharm 26:556–557, 1767. Joshi RK, Majeed-Saidan MA, Abanmi A, et al.: Aplasia cutis congenita with De Groot WG, Postuma R, Hunter AGW: Familial pyloric atresia associated fetus papyraceous. J Am Acad Dermatol 25:1083–1085, 1991. with epidermolysis bullosa. J Pediatr 92:429–431, 1978. Kelly BJ, Samolitis NJ, Xie DL, et al.: Aplasia cutis congenita of the trunk with Demmel U: Clinical aspects of congenital skin defects. I. Congenital skin fetus papyraceus. Pediatr Dermatol 19:326–329, 2002. defects on the head of the newborn. II. Congenital skin defects on the Kosnik EJ, Sayers MP: Congenital scalp defects: aplasia cutis congenita.
Recommended publications
  • The National Economic Burden of Rare Disease Study February 2021
    Acknowledgements This study was sponsored by the EveryLife Foundation for Rare Diseases and made possible through the collaborative efforts of the national rare disease community and key stakeholders. The EveryLife Foundation thanks all those who shared their expertise and insights to provide invaluable input to the study including: the Lewin Group, the EveryLife Community Congress membership, the Technical Advisory Group for this study, leadership from the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH), the Undiagnosed Diseases Network (UDN), the Little Hercules Foundation, the Rare Disease Legislative Advocates (RDLA) Advisory Committee, SmithSolve, and our study funders. Most especially, we thank the members of our rare disease patient and caregiver community who participated in this effort and have helped to transform their lived experience into quantifiable data. LEWIN GROUP PROJECT STAFF Grace Yang, MPA, MA, Vice President Inna Cintina, PhD, Senior Consultant Matt Zhou, BS, Research Consultant Daniel Emont, MPH, Research Consultant Janice Lin, BS, Consultant Samuel Kallman, BA, BS, Research Consultant EVERYLIFE FOUNDATION PROJECT STAFF Annie Kennedy, BS, Chief of Policy and Advocacy Julia Jenkins, BA, Executive Director Jamie Sullivan, MPH, Director of Policy TECHNICAL ADVISORY GROUP Annie Kennedy, BS, Chief of Policy & Advocacy, EveryLife Foundation for Rare Diseases Anne Pariser, MD, Director, Office of Rare Diseases Research, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health Elisabeth M. Oehrlein, PhD, MS, Senior Director, Research and Programs, National Health Council Christina Hartman, Senior Director of Advocacy, The Assistance Fund Kathleen Stratton, National Academies of Science, Engineering and Medicine (NASEM) Steve Silvestri, Director, Government Affairs, Neurocrine Biosciences Inc.
    [Show full text]
  • Neonatal Dermatology Review
    NEONATAL Advanced Desert DERMATOLOGY Dermatology Jennifer Peterson Kevin Svancara Jonathan Bellew DISCLOSURES No relevant financial relationships to disclose Off-label use of acitretin in ichthyoses will be discussed PHYSIOLOGIC Vernix caseosa . Creamy biofilm . Present at birth . Opsonizing, antibacterial, antifungal, antiparasitic activity Cutis marmorata . Reticular, blanchable vascular mottling on extremities > trunk/face . Response to cold . Disappears on re-warming . Associations (if persistent) . Down syndrome . Trisomy 18 . Cornelia de Lange syndrome PHYSIOLOGIC Milia . Hard palate – Bohn’s nodules . Oral mucosa – Epstein pearls . Associations . Bazex-Dupre-Christol syndrome (XLD) . BCCs, follicular atrophoderma, hypohidrosis, hypotrichosis . Rombo syndrome . BCCs, vermiculate atrophoderma, trichoepitheliomas . Oro-facial-digital syndrome (type 1, XLD) . Basal cell nevus (Gorlin) syndrome . Brooke-Spiegler syndrome . Pachyonychia congenita type II (Jackson-Lawler) . Atrichia with papular lesions . Down syndrome . Secondary . Porphyria cutanea tarda . Epidermolysis bullosa TRANSIENT, NON-INFECTIOUS Transient neonatal pustular melanosis . Birth . Pustules hyperpigmented macules with collarette of scale . Resolve within 4 weeks . Neutrophils Erythema toxicum neonatorum . Full term . 24-48 hours . Erythematous macules, papules, pustules, wheals . Eosinophils Neonatal acne (neonatal cephalic pustulosis) . First 30 days . Malassezia globosa & sympoidalis overgrowth TRANSIENT, NON-INFECTIOUS Miliaria . First weeks . Eccrine
    [Show full text]
  • Hair Loss in Infancy
    SCIENCE CITATIONINDEXINDEXED MEDICUS INDEX BY (MEDLINE) EXPANDED (ISI) OFFICIAL JOURNAL OF THE SOCIETÀ ITALIANA DI DERMATOLOGIA MEDICA, CHIRURGICA, ESTETICA E DELLE MALATTIE SESSUALMENTE TRASMESSE (SIDeMaST) VOLUME 149 - No. 1 - FEBRUARY 2014 Anno: 2014 Lavoro: 4731-MD Mese: Febraury titolo breve: Hair loss in infancy Volume: 149 primo autore: MORENO-ROMERO No: 1 pagine: 55-78 Rivista: GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA Cod Rivista: G ITAL DERMATOL VENEREOL G ITAL DERMATOL VENEREOL 2014;149:55-78 Hair loss in infancy J. A. MORENO-ROMERO 1, R. GRIMALT 2 Hair diseases represent a signifcant portion of cases seen 1Department of Dermatology by pediatric dermatologists although hair has always been Hospital General de Catalunya, Barcelona, Spain a secondary aspect in pediatricians and dermatologists 2Universitat de Barcelona training, on the erroneous basis that there is not much in- Universitat Internacional de Catalunya, Barcelona, Spain formation extractable from it. Dermatologists are in the enviable situation of being able to study many disorders with simple diagnostic techniques. The hair is easily ac- cessible to examination but, paradoxically, this approach is often disregarded by non-dermatologist. This paper has Embryology and normal hair development been written on the purpose of trying to serve in the diag- nostic process of daily practice, and trying to help, for ex- ample, to distinguish between certain acquired and some The full complement of hair follicles is present genetically determined hair diseases. We will focus on all at birth and no new hair follicles develop thereafter. the data that can be obtained from our patients’ hair and Each follicle is capable of producing three different try to help on using the messages given by hair for each types of hair: lanugo, vellus and terminal.
    [Show full text]
  • Table I. Genodermatoses with Known Gene Defects 92 Pulkkinen
    92 Pulkkinen, Ringpfeil, and Uitto JAM ACAD DERMATOL JULY 2002 Table I. Genodermatoses with known gene defects Reference Disease Mutated gene* Affected protein/function No.† Epidermal fragility disorders DEB COL7A1 Type VII collagen 6 Junctional EB LAMA3, LAMB3, ␣3, ␤3, and ␥2 chains of laminin 5, 6 LAMC2, COL17A1 type XVII collagen EB with pyloric atresia ITGA6, ITGB4 ␣6␤4 Integrin 6 EB with muscular dystrophy PLEC1 Plectin 6 EB simplex KRT5, KRT14 Keratins 5 and 14 46 Ectodermal dysplasia with skin fragility PKP1 Plakophilin 1 47 Hailey-Hailey disease ATP2C1 ATP-dependent calcium transporter 13 Keratinization disorders Epidermolytic hyperkeratosis KRT1, KRT10 Keratins 1 and 10 46 Ichthyosis hystrix KRT1 Keratin 1 48 Epidermolytic PPK KRT9 Keratin 9 46 Nonepidermolytic PPK KRT1, KRT16 Keratins 1 and 16 46 Ichthyosis bullosa of Siemens KRT2e Keratin 2e 46 Pachyonychia congenita, types 1 and 2 KRT6a, KRT6b, KRT16, Keratins 6a, 6b, 16, and 17 46 KRT17 White sponge naevus KRT4, KRT13 Keratins 4 and 13 46 X-linked recessive ichthyosis STS Steroid sulfatase 49 Lamellar ichthyosis TGM1 Transglutaminase 1 50 Mutilating keratoderma with ichthyosis LOR Loricrin 10 Vohwinkel’s syndrome GJB2 Connexin 26 12 PPK with deafness GJB2 Connexin 26 12 Erythrokeratodermia variabilis GJB3, GJB4 Connexins 31 and 30.3 12 Darier disease ATP2A2 ATP-dependent calcium 14 transporter Striate PPK DSP, DSG1 Desmoplakin, desmoglein 1 51, 52 Conradi-Hu¨nermann-Happle syndrome EBP Delta 8-delta 7 sterol isomerase 53 (emopamil binding protein) Mal de Meleda ARS SLURP-1
    [Show full text]
  • When the Skin Falls Apart……. Neonatal Blistering Disorders
    When the Skin Falls Apart……. Neonatal Blistering Disorders Steven Teich, M.D. Neonatal Blistering Disorders • Suction blisters • Staphylococcal scalded skin syndrome • Aplasia cutis congenita • Congenital herpes simplex virus infection • Bullous congenital ichthyosiform erythroderma • Epidermolysis bullosa Suction Blisters Suction Blisters • Presumed to be induced by vigorous sucking on the affected part in utero • Seen in up to 0.5% of normal newborns at birth • 0.5- to 2-cm oval bullae or erosions on the dorsal aspect of the fingers, thumbs, wrists, lips, or radial aspect of the forearms • Spontaneous resolution without sequelae Staphylococcal Scalded Skin Syndrome (SSSS) Staphylococcal Scalded Skin Syndrome (SSSS) • Blistering skin disorder caused by the epidermolytic toxin- producing S. aureus • Occurs at 2-30 days of life • Abrupt onset of erythema followed by blistering and exfoliation Staphylococcal Scalded Skin Syndrome (SSSS) • SSSS generally begins with localized infection of the conjunctivae, nares, peri-oral region, perineum, or umbilicus • Fever, malaise, lethargy, and poor feeding subsequently develop, and the generalized eruption begins • The rash is characterized by erythema that progresses to large, superficial fragile blisters that rupture easily, leaving behind denuded, erythematous, and tender skin Staphylococcal Scalded Skin Syndrome (SSSS) • Eruption most marked in flexural creases but may involve entire skin • With extensive denudation neonate may have decreased thermoregulatory ability, extensive fluid losses, and
    [Show full text]
  • New Aspects of Cutaneous Mosaicism
    The Journal of Dermatology Vol. 29: 681–692, 2002 Dohi Memorial Lecture New Aspects of Cutaneous Mosaicism Rudolf Happle Abstract The concept of cutaneous mosaicism has today been proven at the cellular level in at least fifteen different skin disorders. We can distinguish five different patterns of mo- saicism, including the phylloid pattern and the lateralization pattern. Etiologically, cuta- neous mosaics can be divided into two large categories, epigenetic mosaicism and genom- ic mosaicism. All forms of epigenetic mosaicism known so far, including the various pat- terns of X-inactivation, appear to be caused by the action of retrotransposons. A new con- cept is functional autosomal mosaicism transmittable through the action of retrotrans- posons, which has been described in mice and dogs and may explain, for example, the fa- milial occurrence of pigmentary mosaicism along the Blaschko lines in human skin. Among the examples of mosaicism of autosomal lethal mutations, phylloid hypomelanosis is a recently recognized neurocutaneous entity caused by mosaic trisomy 13. Possible ex- amples of a type 2 segmental manifestation now include at least fifteen different autoso- mally dominant skin disorders. This phenomenon is most frequently found in gloman- giomatosis, cutaneous leiomyomatosis, and disseminated superficial actinic porokeratosis. Recently proposed examples of didymosis (twin spotting) include cutis tricolor, paired patches of excessive or absent involvement in Darier disease, and didymosis aplasticose- bacea characterized by coexistent aplasia cutis congenita and nevus sebaceus. To the list of possible examples of paradominant inheritance, cutis marmorata telangiectatica congeni- ta and speckled lentiginous nevus syndrome have now been added. Revertant mosaicism giving rise to unaffected skin areas in autosomally recessive cutaneous traits will certainly likewise be recognized more often when clinicians are bearing this concept in mind.
    [Show full text]
  • Boards' Fodder
    boards’ fodder Sound-alikes in dermatology by Jeffrey Kushner, DO, and Kristen Whitney, DO Disease Entity Description Actinic granuloma/ Annular elastolytic Variant of granuloma annulare on sun-damaged skin; annular erythematous giant cell granuloma plaques with slightly atrophic center in sun-exposed areas, which may be precipi- tated by actinic damage. Actinic prurigo PMLE-like disease with photodistributed erythematous papules or nodules and hemorrhagic crust and excoriation. Conjunctivitis and cheilitis are commonly found. Seen more frequently in Native Americans (especially Mestizos). Actinomycetoma “Madura Foot”; suppurative infection due to Nocaria, Actinomadura, or Streptomyces resulting in tissue tumefaction, draining sinuses and extrusion of grains. Actinomycosis “Lumpy Jaw”; Actinomyces israelii; erythematous nodules at the angle of jaw leads to fistulous abscess that drain purulent material with yellow sulfur granules. Acrokeratosis verruciformis Multiple skin-colored, warty papules on the dorsal hands and feet. Often seen in conjunction with Darier disease. Acrodermatitis enteropathica AR; SLC39A4 mutation; eczematous patches on acral, perineal and periorificial skin; diarrhea and alopecia; secondary to zinc malabsorption. Atrophoderma 1) Atrophoderma vermiculatum: Pitted atrophic scars in a honeycomb pattern around follicles on the face; associated with Rombo, Nicolau-Balus, Tuzun and Braun-Falco-Marghescu syndromes. 2) Follicular atrophoderma: Icepick depressions at follicular orifices on dorsal hands/feet or cheeks; associated with Bazex-Dupré-Christol and Conradi- Hünermann-Happle syndromes. 3) Atrophoderma of Pasini and Pierini: Depressed patches on the back with a “cliff-drop” transition from normal skin. 4) Atrophoderma of Moulin: Similar to Pasini/Pierini, except lesions follow the lines of Blaschko. Anetoderma Localized area of flaccid skin due to decreased or absent elastic fibers; exhibits “buttonhole” sign.
    [Show full text]
  • Ocular Manifestations of Inherited Diseases Maya Eibschitz-Tsimhoni
    10 Ocular Manifestations of Inherited Diseases Maya Eibschitz-Tsimhoni ecognizing an ocular abnormality may be the first step in Ridentifying an inherited condition or syndrome. Identifying an inherited condition may corroborate a presumptive diagno- sis, guide subsequent management, provide valuable prognostic information for the patient, and determine if genetic counseling is needed. Syndromes with prominent ocular findings are listed in Table 10-1, along with their alternative names. By no means is this a complete listing. Two-hundred and thirty-five of approxi- mately 1900 syndromes associated with ocular or periocular manifestations (both inherited and noninherited) identified in the medical literature were chosen for this chapter. These syn- dromes were selected on the basis of their frequency, the char- acteristic or unique systemic or ocular findings present, as well as their recognition within the medical literature. The boldfaced terms are discussed further in Table 10-2. Table 10-2 provides a brief overview of the common ocular and systemic findings for these syndromes. The table is organ- ized alphabetically; the boldface name of a syndrome is followed by a common alternative name when appropriate. Next, the Online Mendelian Inheritance in Man (OMIM™) index num- ber is listed. By accessing the OMIM™ website maintained by the National Center for Biotechnology Information at http://www.ncbi.nlm.nih.gov, the reader can supplement the material in the chapter with the latest research available on that syndrome. A MIM number without a prefix means that the mode of inheritance has not been proven. The prefix (*) in front of a MIM number means that the phenotype determined by the gene at a given locus is separate from those represented by other 526 chapter 10: ocular manifestations of inherited diseases 527 asterisked entries and that the mode of inheritance of the phe- notype has been proven.
    [Show full text]
  • Dystrophic Epidermolysis Bullosa
    NLM Citation: Pfendner EG, Lucky AW. Dystrophic Epidermolysis Bullosa. 2006 Aug 21 [Updated 2018 Sep 13]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. Bookshelf URL: https://www.ncbi.nlm.nih.gov/books/ Dystrophic Epidermolysis Bullosa Synonyms: DEB, Epidermolysis Bullosa Dystrophica Ellen G Pfendner, PhD1 and Anne W Lucky, MD2 Created: August 21, 2006; Updated: September 13, 2018. Summary Clinical characteristics Dystrophic epidermolysis bullosa (DEB) is a genetic skin disorder affecting skin and nails that usually presents at birth. DEB is divided into two major types depending on inheritance pattern: recessive dystrophic epidermolysis bullosa (RDEB) and dominant dystrophic epidermolysis bullosa (DDEB). Each type is further divided into multiple clinical subtypes. Absence of a known family history of DEB does not preclude the diagnosis. Clinical findings in severe generalized RDEB include skin fragility manifest by blistering with minimal trauma that heals with milia and scarring. Blistering and erosions affecting the whole body may be present in the neonatal period. Oral involvement may lead to mouth blistering, fusion of the tongue to the floor of the mouth, and progressive diminution of the size of the oral cavity. Esophageal erosions can lead to webs and strictures that can cause severe dysphagia. Consequently, malnutrition and vitamin and mineral deficiency may lead to growth restriction in young children. Corneal erosions can lead to scarring and loss of vision. Blistering of the hands and feet followed by scarring fuses the digits into "mitten" hands and feet, with contractures and pseudosyndactyly. The lifetime risk of aggressive squamous cell carcinoma is higher than 90%.
    [Show full text]
  • Large Hyperpigmented Plaques on the Trunk of a Newborn
    PHOTO CHALLENGE Large Hyperpigmented Plaques on the Trunk of a Newborn Olivia L. Schenck, MD; Adam B. Blechman, MD; Jennifer R. Kaley, MD; Kenneth E. Greer, MD Eligible for 1 MOC SA Credit From the ABD This Photo Challenge in our print edition is eligible for 1 self-assessment credit for Maintenance of Certification from the American Board of Dermatology (ABD). After completing this activity, diplomates can visit the ABD website (http://www.abderm.org) to self-report the credits under the activity title “Cutis Photo Challenge.” You may report the credit after each activity is completed or after accumulating multiple credits. A 4-day-old girl with no notable medical history presented with 2 pink lesions on the right side of the back and left side of the flank. Both lesions were present at birth and hadcopy not changed in size, shape, or color in the first 4 days of life. She had no consti- tutional symptoms. The child was a full-term new- born, and her mother experienced no pregnancy or delivery complications.not She had no family history of similar skin findings. Do What’s the diagnosis? a. aplasia cutis congenitaCUTIS b. connective tissue nevus c. cutaneous mastocytoma d. epidermal nevus (epidermolytic type) e. epidermolysis bullosa PLEASE TURN TO PAGE 261 FOR PHOTO CHALLENGE DISCUSSION Dr. Schenck is from the Department of Dermatology, Northwestern University, Chicago, Illinois. Drs. Blechman, Kaley, and Greer are from the Department of Dermatology, University of Virginia Health System, Charlottesville. The authors report no conflict of interest. Correspondence: Adam B. Blechman, MD, University of Virginia Health System, Department of Dermatology, 1221 Lee St, PO Box 800718, Charlottesville, VA 22908-0718 ([email protected]).
    [Show full text]
  • Congenital: Growths-Conditions-Vascular Lesions-Hair-Nails Epidermolysis-Ichthyosis-Mastocytosis-Neurofibromatosis-Tuberous Sclerosis-Xeroderma
    Congenital: Growths-Conditions-Vascular Lesions-Hair-Nails Epidermolysis-Ichthyosis-Mastocytosis-Neurofibromatosis-Tuberous sclerosis-Xeroderma Other congenital malformations (Q80-Q85) Q80 Congenital ichthyosis Excludes1: Refsum's disease (G60.1) Q80.0 Ichthyosis vulgaris Q80.1 X-linked ichthyosis Q80.2 Lamellar ichthyosis Collodion baby Q80.3 Congenital bullous ichthyosiform erythroderma Q80.4 Harlequin fetus Q80.8 Other congenital ichthyosis Q80.9 Congenital ichthyosis, unspecified Q81 Epidermolysis bullosa Q81.0 Epidermolysis bullosa simplex Excludes1: Cockayne's syndrome (Q87.1) Q81.1 Epidermolysis bullosa letalis Herlitz' syndrome Q81.2 Epidermolysis bullosa dystrophica Q81.8 Other epidermolysis bullosa Q81.9 Epidermolysis bullosa, unspecified Q82 Other congenital malformations of skin Excludes1: acrodermatitis enteropathica (E83.2) congenital erythropoietic porphyria (E80.0) pilonidal cyst or sinus (L05.-) Sturge-Weber (-Dimitri) syndrome (Q85.8) Q82.0 Hereditary lymphedema Q82.1 Xeroderma pigmentosum Q82.2 Mastocytosis Urticaria pigmentosa Excludes1: malignant mastocytosis (C96.2) Q82.3 Incontinentia pigmenti Q82.4 Ectodermal dysplasia (anhidrotic) Excludes1: Ellis-van Creveld syndrome (Q77.6) Q82.5 Congenital non-neoplastic nevus Birthmark NOS Flammeus Nevus Portwine Nevus Sanguineous Nevus Strawberry Angioma Strawberry Nevus Vascular Nevus NOS Verrucous Nevus Excludes2: Café au lait spots (L81.3) lentigo (L81.4) nevus NOS (D22.-) araneus nevus (I78.1) melanocytic nevus (D22.-) pigmented nevus (D22.-) spider nevus (I78.1) stellar
    [Show full text]
  • A Clinical Study on Genodermatoses and Their Effect On
    A CLINICAL STUDY ON GENODERMATOSES AND THEIR EFFECT ON QUALITY OF LIFE – PROSPECTIVE OBSERVATIONAL STUDY IN A TERTIARY CARE HOSPITAL Dissertation Submitted to THE TAMILNADU DR.M.G.R. MEDICAL UNIVERSITY IN PARTIAL FULFILMENT FOR THE AWARD OF THE DEGREE OF DOCTOR OF MEDICINE IN DERMATOLOGY, VENEREOLOGY & LEPROSY Register No.: 201730253 BRANCH XX MAY 2020 DEPARTMENT OF DERMATOLOGY VENEREOLOGY & LEPROSY TIRUNELVELI MEDICAL COLLEGE TIRUNELVELI -11 BONAFIDE CERTIFICATE This is to certify that the dissertation titled as “A CLINICAL STUDY ON GENODERMATOSES AND THEIR EFFECT ON QUALITY OF LIFE – PROSPECTIVE OBSERVATIONAL STUDY IN A TERTIARY CARE HOSPITAL” submitted by Dr.P.KARTHIKRAJA to the Tamil Nadu Dr.M.G.R. Medical University, Chennai,in partial fulfilment of the requirement for the award of the Degree of DOCTOR OF MEDICINE in DERMATOLOGY, VENEREOLOGY AND LEPROSY during the academic period 2017 – 2020 is a bonafide research work carried out by him under direct supervision & guidance. Dr.P.Nirmaladevi MD., Dr.S.M.Kannan MS , MCh., Professor and HOD The Dean Department of Dermatology,Venereology &Leprosy Tirunelveli Medical College Tirunelveli Medical College Tirunelveli Tirunelveli CERTIFICATE This is to certify that the dissertation titled as “A CLINICAL STUDY ON GENODERMATOSES AND THEIR EFFECT ON QUALITY OF LIFE – PROSPECTIVE OBSERVATIONAL STUDY IN A TERTIARY CARE HOSPITAL” submitted by Dr.P.KARTHIKRAJA is a original work done by him in the Department of Dermatology,Venereology & Leprosy,Tirunelveli Medical College,Tirunelveli for the award
    [Show full text]